ALyS505N-0 (not containing IL-2) Recombinant human insulin, trans-ferrin, human albumin IL-2 is not included. ALyS505N has been developed for immune cell therapy research, and all of its proteins are human type serum-free culture. High proliferation performance can be expected even if serum usage is greatly reduced. Key Facts
The use of anti-CD3 antibodies or plant lectins to support the high proliferation of activated peripheral blood T lymphocytes. There arefour types of IL-2, IL-2 free, IL-2 containing 175 IU / ml, 700 IU / ml and1,000 IU / ml. Allproteins are humanized and recombinant proteins and heat-treated serum proteins. Protein ingredients derived from heterologous animals are not used. The amount of serum used can be greatly reduced. With a small amount of serum added (0.1-2%), the effect of cell proliferation over conventional serum-supplemented culture medium can be expected. For primary cultures (activated cultures) of peripheral blood lymphocytes in ALyS505N medium, the addition of small amounts of serum or plasma (1-5%) is recommended. Serum addition is not necessary after self-proliferation begins. Packing types include plastic bottles and gas permeable bag. The cell culture bag permeates the gas that is optimal for cell culture. The realization of closed-system culture lowers the risk of contamination and enables mass culture Product Name | Description | Catalog Code | Unit | ALyS505N-0 | Serum-free culture medium for immune cell therapy research ( Not containing IL-2 ) | 1020P10 1020C10 | 1,000ml ( PET ) 1,000ml ( CB ) | ALyS505N-175 | Serum-free culture medium for immune cell therapy research ( IL-2 175 IU / ml ) | 10217P10 10217C10 | 1,000ml ( PET ) 1,000ml ( CB ) | ALyS505N-7 | Serum-free culture medium for immune cell therapy research ( IL-2 700 IU / ml ) | 1027P10 1027C10 | 1,000ml ( PET ) 1,000ml ( CB ) | ALyS505N-10 | Serum-free culture medium for immune cell therapy research ( IL-2 1,000 IU / ml ) | 10210P10 10210C10 | 1,000ml ( PET ) 1,000ml ( CB ) |
Contact Tel : 02-3415-7811 Email : bio@dhnp.co.kr
|